Toboroz
A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
NCT07498426· 3. fázis· Novartis Pharmaceuticals· Forrás
Contact: Anna Leonard-Leumas
Toboroz
Continuous Dual Aspiration Technique With Zoom System for Stroke
NCT07491952· Imperative Care, Inc.· Forrás
Contact: Jessica Henry
Toboroz
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
NCT07277231· 3. fázis· BeOne Medicines· Forrás
Contact: Study Director
Toboroz
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380· 3. fázis· Eli Lilly and Company· Forrás
Contact: Brian Halbert (principal investigator)
Toboroz
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
NCT07213804· 3. fázis· Eli Lilly and Company· Forrás
Contact: Katrina Wade (principal investigator)
Toboroz
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
NCT06973187· 3. fázis· BeOne Medicines· Forrás
Contact: Study Director
Fut, nem toboroz
PSMA PET Combined With MRI for the Detection of PCa
NCT07052214· 3. fázis· Telix Pharmaceuticals (Innovations) Pty Limited· Forrás
Toboroz
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
NCT06607458· 2. fázis· Delcath Systems Inc.· Forrás
Contact: Matthew Cooney, MD
Toboroz
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
NCT06721013· 1/2. fázis· Eli Lilly and Company· Forrás
Toboroz
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
NCT06890598· 3. fázis· Eli Lilly and Company· Forrás
Contact: Ralph Millett (principal investigator)
Fut, nem toboroz
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
NCT06869785· 3. fázis· Novartis Pharmaceuticals· Forrás
Toboroz
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
NCT06680830· 2. fázis· Neuron23 Inc.· Forrás
Contact: Anna Leonard-Leumas
Toboroz
Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula
NCT06516653· Laminate Medical Technologies· Forrás
Contact: Shannon Williams
Toboroz
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
NCT06662786· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
ADVENT Post Approval Study
NCT06431815· Boston Scientific Corporation· Forrás
Fut, nem toboroz
Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)
NCT06486441· 3. fázis· Gilead Sciences· Forrás
Toboroz
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
NCT06282575· 3. fázis· Jazz Pharmaceuticals· Forrás
Contact: Clinical Trial Disclosure & Transparency
Toboroz
Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
NCT06263426· Johns Hopkins University· Forrás
Contact: Jonathan Hand, MD
Fut, nem toboroz
P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies
NCT06014762· 1. fázis· Poseida Therapeutics, Inc.· Forrás
Toboroz
The Fourth Left Atrial Appendage Occlusion Study
NCT05963698· Hamilton Health Sciences Corporation· Forrás
Contact: Richard Zweifler, MD (principal investigator)
Fut, nem toboroz
Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL)
NCT06073821· 3. fázis· BeOne Medicines· Forrás
Fut, nem toboroz
TheraSphere With Durvalumab and Tremelimumab for HCC
NCT05063565· 2. fázis· Boston Scientific Corporation· Forrás
Fut, nem toboroz
Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)
NCT05953337· ABK Biomedical· Forrás
Toboroz
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
NCT05803941· 4. fázis· Novartis Pharmaceuticals· Forrás
Contact: Stephen Bardot (principal investigator)
Toboroz
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
NCT05762107· 2. fázis· Zucara Therapeutics Inc.· Forrás
Contact: Teva Williams
Fut, nem toboroz
A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors
NCT05848739· 1. fázis· Sapience Therapeutics· Forrás
Fut, nem toboroz
A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM
NCT03862430· 2. fázis· NuvOx LLC· Forrás
Fut, nem toboroz
A Study Investigating the Efficacy and Safety of Alcestobart (LBL-007) Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine in Participants With Unresectable or Metastatic Colorectal Cancer
NCT05609370· 1/2. fázis· BeiGene· Forrás
Toboroz
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
NCT05614739· 1. fázis· Eli Lilly and Company· Forrás
Fut, nem toboroz
A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)
NCT05506943· 2/3. fázis· Compass Therapeutics· Forrás
Fut, nem toboroz
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
NCT05024773· 3. fázis· Fidia Farmaceutici s.p.a.· Forrás
Fut, nem toboroz
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
NCT05538130· 1. fázis· Pfizer· Forrás
Toboroz
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
NCT05135091· 3. fázis· Neurona Therapeutics· Forrás
Contact: Neydin Osorio, BS, CRC
Fut, nem toboroz
A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors
NCT05135559· 3. fázis· Novo Nordisk A/S· Forrás
Fut, nem toboroz
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
NCT05156281· 3. fázis· Novartis Pharmaceuticals· Forrás
Toboroz
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
NCT05065216· 2/3. fázis· DiaMedica Therapeutics Inc· Forrás
Contact: Jessica Henry
Toboroz
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
NCT05051722· Mayo Clinic· Forrás
Contact: Ashley Samuel, CRC
Fut, nem toboroz
An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
NCT04720157· 3. fázis· Novartis Pharmaceuticals· Forrás
Toboroz
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
NCT04649242· 3. fázis· Pfizer· Forrás
Fut, nem toboroz
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
NCT04607421· 3. fázis· Pfizer· Forrás
Toboroz
Black and African Americans Connections to Parkinson's Disease (BLAAC PD)
NCT06719583· Michael J. Fox Foundation for Parkinson's Research· Forrás
Contact: Dominique Thomas
Fut, nem toboroz
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-MutatedProstatic Neoplasms (mCSPC)
NCT04497844· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study
NCT04215146· 2. fázis· Oncolytics Biotech· Forrás
Fut, nem toboroz
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
NCT04291105· 2. fázis· Vyriad, Inc.· Forrás
Fut, nem toboroz
Clinical Trial Multi-analyte Blood Test
NCT03694600· Helio Genomics· Forrás
Fut, nem toboroz
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
NCT03748641· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
9-ING-41 in Patients With Advanced Cancers
NCT03678883· 2. fázis· Actuate Therapeutics Inc.· Forrás
Fut, nem toboroz
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
NCT03466411· 2/3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
NCT03695978· Octapharma· Forrás
Contact: Cristina Solomon, MD
Fut, nem toboroz
Study Evaluating Safety, Tolerability and Pharmacokinetics (PK) of Tarlatamab in Adults With Small Cell Lung Cancer (SCLC)
NCT03319940· 1. fázis· Amgen· Forrás
Showing 50 of 57.